Please provide your email address to receive an email when new articles are posted on . Mistrust is a key barrier when discussing tumor genomic profiling with African American patients with cancer.

This article is part of a Health Affairs Forefront short series, “Enhancing Value By Evaluating Health Care Services.” The series discusses ways to extend the use of tools for clinical and economic ...

Delivering high-quality care starts with understanding what matters most to each patient. Clinicians can’t choose treatments that match patients’ priorities and values until they engage with them. The ...

The second key factor is radical personalisation. Moving beyond basic patient segmentation, true personalisation means ...

The IGA score, BSA, and DLQI are instruments that Megan Rogge, MD, dermatologist at McGovern Medical School, UTHealth Houston, uses to select and justify treatment options for prior authorization in ...

We’re all frustrated by the high cost of US health care and a system that’s challenging for patients to navigate and does not consider patients’ goals and wishes. Both the public and private sectors ...

Subcutaneous nivolumab injection marks a significant advancement in cancer therapy, offering faster administration than traditional intravenous methods. The shift to subcutaneous delivery could lead ...